Search Results 1121-1130 of 18451 for prednisone
... prednisone for at least 1 month prior. NOTE: low dose steroid use for control of nausea and vomiting will be allowed; topical steroid use and inhaled ...
Therapeutic doses of corticosteroids (defined as > 20 mg/day prednisone or equivalent) within 14 days before leukapheresis. Physiologic replacement, topical ...
Receiving chronic systemic steroid therapy (in doses exceeding 10 mg daily of prednisone equivalent) or any other form of immunosuppressive therapy within 14 ...
A migraine aura involving your vision affects both eyes. Visual symptoms don't last long. You may see: Flashes of light. Zigzagging patterns. Blind spots.
Chronic doses of glucocorticoids more than twice physiologic (e.g., daily prednisone or prednisolone >10 mg daily, hydrocortisone >40 mg daily, or dexamethasone ...
Patient is considered a candidate for initiating CYP-17 inhibitors abiraterone acetate and prednisone after failure of hormonal therapy and has no contra- ...
... prednisone for the 28 days immediately up to enrollment. Cohort 1 and 2 only: Subjects treated with JAK2 inhibitors ≤ 112 days immediately up to the ...
Endometriosis. Fibrocystic breast disease (cysts in the breasts). Hereditary angioedema (swelling of the different parts of the body, such as abdomen or stomach ...
As people age, the spinal disks in the neck shrink and bone spurs often develop. If symptoms occur, nonsurgical treatments are usually effective.
Subjects receiving oral corticosteroids may continue their use during the study provided the dose (prednisone up to 20 mg/day, budesonide up to 9 mg/day) ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!